Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael D Edstein

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Malaria Journal|February 9, 2022
Cross-sectional study of asymptomatic malaria and seroepidemiological surveillance of seven districts in Gia Lai province, VietnamNguyen Ngoc San, Nguyen Xuan Kien, Nguyen Duc Manh, et al.
Journal of Medicinal Chemistry|June 13, 2012
Antimalarial activity of pyrroloiminoquinones from the Australian marine sponge Zyzzya spRohan A Davis, Malcolm S Buchanan, Sandra Duffy, et al.
The Journal of Antimicrobial Chemotherapy|July 25, 2007
Antimalarial pharmacodynamics and pharmacokinetics of a third-generation antifolate--JPC2056--in cynomolgus monkeys using an in vivo in vitro modelMichael D Edstein, Barbara M Kotecka, Arba L Ager, et al.
Antimicrobial Agents and Chemotherapy|September 27, 2021
Pyronaridine-Artesunate (Pyramax) for Treatment of Artemisinin- and Piperaquine-Resistant Plasmodium falciparum in the Central Highlands of VietnamNguyen Duc Manh, Nguyen Van Thanh, Huynh Hong Quang, et al.
Antimicrobial Agents and Chemotherapy|July 24, 2024
Therapeutic efficacy of pyronaridine-artesunate (Pyramax) in treating <i>Plasmodium vivax</i> malaria in the central highlands of VietnamNguyen Duc Manh, Nguyen Van Thanh, Huynh Hong Quang, et al.
Antimicrobial Agents and Chemotherapy|January 10, 2018
Characterization of the Preclinical Pharmacology of the New 2-Aminomethylphenol, JPC-3210, for Malaria Treatment and PreventionGeoffrey W Birrell, Gavin D Heffernan, Guy A Schiehser, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 22, 2026
Population Pharmacokinetics and Pharmacodynamics of Paracetamol in Malaysian Patients With Plasmodium knowlesi MalariaThanaporn Wattanakul, Daniel J Cooper, Katherine Plewes, et al.
ACS Chemical Biology|November 22, 2017
Design of Plasmodium vivax Hypoxanthine-Guanine Phosphoribosyltransferase Inhibitors as Potential Antimalarial TherapeuticsDianne T Keough, Dominik Rejman, Radek Pohl, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 16, 2023
Characterizing the Blood-Stage Antimalarial Activity of Tafenoquine in Healthy Volunteers Experimentally Infected With Plasmodium falciparumBridget E Barber, Azrin N Abd-Rahman, Rebecca Webster, et al.
Antimicrobial Agents and Chemotherapy|October 22, 2014
JPC-2997, a new aminomethylphenol with high in vitro and in vivo antimalarial activities against blood stages of PlasmodiumGeoffrey W Birrell, Marina Chavchich, Arba L Ager, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Malaria Journal|February 9, 2022
Cross-sectional study of asymptomatic malaria and seroepidemiological surveillance of seven districts in Gia Lai province, VietnamNguyen Ngoc San, Nguyen Xuan Kien, Nguyen Duc Manh, et al.
Journal of Medicinal Chemistry|June 13, 2012
Antimalarial activity of pyrroloiminoquinones from the Australian marine sponge Zyzzya spRohan A Davis, Malcolm S Buchanan, Sandra Duffy, et al.
The Journal of Antimicrobial Chemotherapy|July 25, 2007
Antimalarial pharmacodynamics and pharmacokinetics of a third-generation antifolate--JPC2056--in cynomolgus monkeys using an in vivo in vitro modelMichael D Edstein, Barbara M Kotecka, Arba L Ager, et al.
Antimicrobial Agents and Chemotherapy|September 27, 2021
Pyronaridine-Artesunate (Pyramax) for Treatment of Artemisinin- and Piperaquine-Resistant Plasmodium falciparum in the Central Highlands of VietnamNguyen Duc Manh, Nguyen Van Thanh, Huynh Hong Quang, et al.
Antimicrobial Agents and Chemotherapy|July 24, 2024
Therapeutic efficacy of pyronaridine-artesunate (Pyramax) in treating <i>Plasmodium vivax</i> malaria in the central highlands of VietnamNguyen Duc Manh, Nguyen Van Thanh, Huynh Hong Quang, et al.
Antimicrobial Agents and Chemotherapy|January 10, 2018
Characterization of the Preclinical Pharmacology of the New 2-Aminomethylphenol, JPC-3210, for Malaria Treatment and PreventionGeoffrey W Birrell, Gavin D Heffernan, Guy A Schiehser, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 22, 2026
Population Pharmacokinetics and Pharmacodynamics of Paracetamol in Malaysian Patients With Plasmodium knowlesi MalariaThanaporn Wattanakul, Daniel J Cooper, Katherine Plewes, et al.
ACS Chemical Biology|November 22, 2017
Design of Plasmodium vivax Hypoxanthine-Guanine Phosphoribosyltransferase Inhibitors as Potential Antimalarial TherapeuticsDianne T Keough, Dominik Rejman, Radek Pohl, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 16, 2023
Characterizing the Blood-Stage Antimalarial Activity of Tafenoquine in Healthy Volunteers Experimentally Infected With Plasmodium falciparumBridget E Barber, Azrin N Abd-Rahman, Rebecca Webster, et al.
Antimicrobial Agents and Chemotherapy|October 22, 2014
JPC-2997, a new aminomethylphenol with high in vitro and in vivo antimalarial activities against blood stages of PlasmodiumGeoffrey W Birrell, Marina Chavchich, Arba L Ager, et al.
Pageof 9